Drug intelligence / Profile preview

Active Comparator 4

Development stage: Unknown
Modality: Inhalation Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems

Overview

Active Comparator 4 is a combination product administered intramuscularly to older adults (OA) as part of a Phase 2a randomized, observer-blind, dose-finding study. This study evaluates the immunogenicity and safety of mRNA-based multivalent seasonal influenza vaccine candidates. The specific components or mechanism of action of Active Comparator 4 are not disclosed in the provided context, as it serves as a comparator in the trial.

Beyond the preview

Go deeper on Active Comparator 4.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Active Comparator 4.

Explore the full profile